Tuesday, April 20, 2021

Applied DNA Sciences, Inc. (APDN) Stock Price Soared Over 139.8% Since The Beginning Of The Year. Here’s What Happened

Applied DNA Sciences, Inc. (NASDAQ: APDN) a producer of pre-clinical nucleic acid-based therapeutic drugs, recently reported being a part of a pro bono Material Transfer Agreement (MTA) that provides an instantaneous surveillance program for lookout and inspection of SARS-CoV-2 mutated strains and unique variants of the virus in Northwell’s COVID-positive specimens.

The plan of action presently conclude the analysis of over 2,000 samples, with preliminary results from almost 360 specimens showing that a staggering 80% of samples tested on APND qPCR assays consist of one mutation at least.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Stats produced from the program will allow Northwell to make more effective use of the expensive and gradual process in next-generation sequencing (NGS) essential to adequately identify particular VoCs and their prior forms.

APDN Purchase Order Had A Sudden Surge

APDN reported a purchase order for its Linea™ COVID-19 Assay Kit for provision of 10,000 tests, With the balance to be delivered in the following fiscal year. Linea has been offering surveillance testing keeping in accordance CDC, FDA, and CMS guidelines. Pooled Sampling for virus detection, which was regulated by the company in regards to testing guidance.

However, LinearDNA does not solely produce biological products with a diversified product line such as supply chain security, pharmaceuticals and cannabis.

Applied DNA Sciences also announced Q1 sales of $1.62 million. Earnings decreased and produced a loss of $2.97 million, hence a 26.64% plummet compared to the previous quarter. In Q4, APDN generateds$314.00 thousand in sales, however, lost an accumulated $4.05 million in earnings.

Conclusion

APDN has invested in the lucrative field of virus sampling and testing amidst a pandemic. A substantial increase in the stock price since the start of the year is a positive sign in terms of revenue and has been a healthy indicator for the company’s future valuation.

Latest news

What to Expect When Philip Morris International Inc. [PM] Releases Earnings

Earnings from Philip Morris International Inc. are scheduled on April 20, 2021, before the market opens. It is expected that the company will...

Johnson & Johnson [JNJ]: What to Expect when It Reports Earnings

Earnings from Johnson & Johnson are scheduled on April 20, 2021, before the market opens. It is expected that the company will report...

What to Watch When The Procter & Gamble Company [PG] Reports Quarterly Earnings

Earnings from The Procter & Gamble Company are scheduled on April 20, 2021, before the market opens. It is expected that the company...

What the analysts are predicting for KeyCorp’s [KEY] earnings

Earnings from KeyCorp are scheduled on April 20, 2021, before the market opens. It is expected that the company will report strong earnings...

Related news

What to Expect When Philip Morris International Inc. [PM] Releases Earnings

Earnings from Philip Morris International Inc. are scheduled on April 20, 2021, before the market opens. It is expected that the company will...

Johnson & Johnson [JNJ]: What to Expect when It Reports Earnings

Earnings from Johnson & Johnson are scheduled on April 20, 2021, before the market opens. It is expected that the company will report...

What to Watch When The Procter & Gamble Company [PG] Reports Quarterly Earnings

Earnings from The Procter & Gamble Company are scheduled on April 20, 2021, before the market opens. It is expected that the company...

What the analysts are predicting for KeyCorp’s [KEY] earnings

Earnings from KeyCorp are scheduled on April 20, 2021, before the market opens. It is expected that the company will report strong earnings...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.